CLINICAL_TRIALS
research
· 2026-04-24
Clinical Trial Update: Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants [Phase 1]
Summary
This is a Phase 1 drug-drug interaction study of ZT002 injection in overweight and obese participants. The study is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing QL Biopharmaceutical Co.,Ltd | Conditions: Overweight,Obesity | Phase 1 | Status: NOT_YET_RECRUITING